Exelixis
EXEL
#1835
Rank
$10.87 B
Marketcap
$40.58
Share price
-1.43%
Change (1 day)
9.09%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company